indications for semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough the treatment of obesity semaglutide fda approved indications FDA

& Buchanan, K

GLP-1 medications work by: Slowing stomach emptying, which helps patients feel fuller longer Reducing appetite and food cravings Regulating blood sugar levels Improving insulin sensitivity Traditionally, most GLP-1 medications have been delivered through injections

In a 52 week Phase 2 trial, overweight/obese individuals without diabetes lost 13.7% of their body weight (placebo subtracted) after receiving maridebart cafraglutide (420 mg once monthly), and overweight/obese individuals with diabetes lost 10.6% of their body weight and saw a decrease in HbA 1c of ~17 mmol/mol (1.5%, placebo subtracted) after receiving maridebart cafraglutide at the same dose (Table 2) [55]

Understanding the differences between medical weight loss vs med spa programs can help you make a more informed decision